Biochemical Engineering

AstraZeneca nears temporary OK for COVID-19 vaccine, plots extra trial

AstraZeneca nears temporary OK for COVID-19 vaccine, plots extra trial

30th November 2020

The UK government has asked the national regulator to consider clearing AstraZeneca’s COVID-19 vaccine for temporary supply as soon as it receives safety, quality and efficacy data. Requesting use of the fast track positions the UK to be among the first countries to begin a COVID-19 vaccination campaign. Source: Fierce Biotech 30/11/2020


Back to group news